ScienHub

People attending a scientific conference Test tubes in a lab tray People attending a conference

We enable the scientific community to achieve excellence

At ScienHub we offer comprehensive solutions for the implementation of clinical research and knowledge transfer. We accompany the scientific community in all phases of its specialized work, ensuring the quality and effectiveness of the results obtained.

Units

  • ScienHub
    Research Support

    Unit specialized in the management and development of clinical studies. We promote research by offering comprehensive support in the management and implementation of projects, ensuring their quality and offering maximum reliability of the results obtained.

  • ScienHub
    Education

    Unit dedicated to the dissemination and knowledge transfer in the medical and scientific field. We promote the professional growth of the scientific community by creating spaces to share and expand knowledge.

ScienHub in 2023

  • ScienHub

    Support to multiple therapeutic areas

    • Cardiology
    • Covid-19 and Long-Covid
    • Dermatology
    • Gastroenterology
    • Immunology
    • Nephrology
    • Oncology
    • Rheumatology
    • Urology
    • HIV
  • Education

    +50
    activities

    We have offered a wide variety of courses, conferences, congresses and webinars in all formats (face-to-face, hybrid and online).

  • Education

    +3.180
    attendees

    The professionals who attended our training activities in 2023 were primarily specialist doctors (27.1%), followed by primary care physicians (15.1%), and students (13.3%).

  • CRO

    60
    studies managed

    From the Contract Research Organization (CRO), we have managed 23 clinical trials, 20 research projects, 10 investigations involving medical devices, 4 cohorts, and 3 observational studies with pharmaceuticals.

  • Test tubes in a tray
  • CTU

    59
    studies implemented

    From the Clinical Trials Unit (CTU), we have implemented 59 clinical studies: 4 of them were Phase I and II, and the rest were Phase III and IV trials, as well as cohorts.

  • ScienHub in 2023

  • ScienHub

    Support to multiple therapeutic areas

    • Cardiology
    • Covid-19 and Long-Covid
    • Dermatology
    • Gastroenterology
    • Immunology
    • Nephrology
    • Oncology
    • Rheumatology
    • Urology
    • HIV
  • Education

    +50
    activities

    We have offered a wide variety of courses, conferences, congresses and webinars in all formats (face-to-face, hybrid and online).

  • Education

    +3.180
    attendees

    The professionals who attended our training activities in 2023 were primarily specialist doctors (27.1%), followed by primary care physicians (15.1%), and students (13.3%).

  • CRO

    60
    studies managed

    From the Contract Research Organization (CRO), we have managed 23 clinical trials, 20 research projects, 10 investigations involving medical devices, 4 cohorts, and 3 observational studies with pharmaceuticals.

  • Test tubes in a tray
  • CTU

    59
    studies implemented

    From the Clinical Trials Unit (CTU), we have implemented 59 clinical studies: 4 of them were Phase I and II, and the rest were Phase III and IV trials, as well as cohorts.

  • The CTU unit participates in the National Congress on AIDS and STIs

    The CTU unit from ScienHub Research Support presented two posters at the XXI National Congress on AIDS and STIs, organized by SEISIDA. The congress focused on the theme “The Ages of HIV,” addressing various perspectives and challenges related to aging and the diversity of PLHIV.

    • “Beyond Comorbidities: Over50 Cohort of PLHIV ≥ 50 Years Old Compared to a Control Group”: The results showed a higher prevalence of sleep disorders, chronic pain, sexual dysfunction, falls, depression, and loneliness in PLHIV compared to a control group. This underscores the need for specific approaches to geriatric care in PLHIV.
    • “Redesigning HIV Care: A Significant Shift in the Profile of Individuals Newly Diagnosed with HIV”: The study concluded that there has been a significant increase in HIV diagnoses in primary care, suggesting a possible lack of information about the infection, a greater diversity of affected population groups, an increase in detection among women, and an increase in AIDS diagnoses. This highlights the need to adopt differentiated approaches for newly diagnosed individuals.

    The participation of the CTU team in the congress underscores our commitment to research, advancing the understanding and improvement of care for people with HIV.

    Meet the CTU
  • We commemorate International Clinical Trials Day

    Today, May 20th, we commemorate a historic milestone in medicine: the first clinical trial conducted by Scottish doctor James Lind in 1747. This pioneering trial, which identified a lack of vitamin C as the cause of scurvy among sailors in the British Navy, laid the foundation for modern clinical research.

    In the past six decades, clinical research has transformed our health and well-being and has contributed to achieving goals such as:

    • Life expectancy in Europe has increased by almost 10 years.
    • The mortality rate from HIV/AIDS has decreased by over 80% since the 1980s.
    • The cancer mortality rate is 20% lower since the 1990s.

    Source

    In every clinical trial, the true heroes are the patients. Their active participation is key to the development of new therapies and treatments.

    At ScienHub Research Support, we are committed to advancing research by providing comprehensive support in the management and implementation of clinical studies. From our CRO, we handle the management of clinical trials in all phases, including bureaucratic procedures, monitoring, and data management. From the CTU, we implement clinical trials strictly adhering to current regulations. We ensure the rights, safety, and well-being of the participants, as well as the quality of the data obtained.

    Learn more
  • Center of Excellence in HIV and Aging

    Last April, ScienHub Education organized the 2nd workshop as a Center of Excellence in HIV and Aging with the aim of consolidating the recognition of the Fight Infections Foundation as specialists in HIV and Aging. In 2023, the foundation was accredited as a Center of Excellence in HIV and Aging by the Gilead Sciences program, highlighting its dedication to research, treatment, and care for people living with HIV.

    The training, aimed at a small group of medical professionals from hospital centers in Catalonia, was designed with the goal of ensuring healthy aging and a better quality of life, addressing medical, social, psychosocial, functional, cognitive, and geriatric aspects.

    Dr. Eugènia Negredo, head of the HIV section at the Germans Trias i Pujol University Hospital and researcher at the Fight against Infections Foundation, coordinated the workshop. The activity involved experts from her team and regular collaborators, thus reinforcing the foundation’s commitment to excellence in HIV and aging care.

    Learn more
  • Study Hipra HH-4: Promising vaccine against SARS-CoV-2 in immunosuppressed adults

    The Hipra HH-4 study is a multicenter investigation aimed at evaluating the immunogenicity and safety of an RBD fusion vaccine (PHH-IV) against SARS-COV-2. This study specifically focused on adults with immunosuppressive conditions who were already vaccinated against COVID-19.

    The CRO ScienHub Research Support coordinated the monitoring tasks among the three recruiting centers, and the CTU implemented the study at our center, collaborating closely and determinedly with the respective research teams.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop